🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine the safety and tolerability of a ...
Status
Completed
Location
Multiple Locations
Start Date
2005-07
Trial ID
NCT00127803
Primary objective: To compare the event rate of CDI in groups assigned to A...
Status
Completed
Location
Multiple Locations
Start Date
2009-02
Trial ID
NCT00772343
This study will further evaluate the ACAM-CDIFF™ vaccine in a population of...
Status
Completed
Location
Multiple Locations
Start Date
2010-10
Trial ID
NCT01230957
Treatments Being Tested
The aim of the study is to evaluate a candidate C. difficile Toxoid Vaccine...
Status
Completed
Location
Multiple Locations
Start Date
2013-07
Trial ID
NCT01896830
Treatments Being Tested
The Clover trial is evaluating an investigational vaccine that may help to ...
Status
Completed
Location
North Alabama Research Center, LLC
Start Date
2017-03-29
Trial ID
NCT03090191
Treatments Being Tested
This Phase I, randomized, placebo-controlled, double-blinded, dose ranging ...
Status
Terminated
Location
Multiple Locations
Start Date
2006-03
Trial ID
NCT00772954
This study will investigate a Clostridium difficile vaccine in healthy adul...
Status
Completed
Location
Coastal Clinical Research, Inc.
Start Date
2018-07-31
Trial ID
NCT03579459
Treatments Being Tested
The purpose of this study is to determine the safety and tolerability of a ...
Status
Completed
Location
Orlando Clinical Research Center
Start Date
2005-11
Trial ID
NCT00214461
An antibody is a substance your body makes to fight off infection. This stu...
Status
Active Not Recruiting
Location
HOPE Research Institute
Start Date
2023-03-23
Trial ID
NCT05805826
This study will investigate a Clostridium difficile vaccine in adults 50 ye...
Status
Completed
Location
North Alabama Research Center, LLC
Start Date
2019-04-01
Trial ID
NCT03918629
Treatments Being Tested